• ALung Technologies, now a part of LivaNova

ALung Technologies, based in Pittsburgh, is a medical technology company focused on respiratory support devices. It specializes in the Hemolung™, an extracorporeal artificial lung designed to support or replace lung function in patients with acute respiratory failure. This device provides about 50% of a patient's respiratory needs, allowing for lung healing while minimizing the need for intubation and mechanical ventilation. The Hemolung aims to improve patient outcomes by reducing complications associated with traditional ventilators. In May 2022, ALung became a wholly owned subsidiary of LivaNova, a global medical device company known for its cardiac and neuromodulation devices. This acquisition enhances LivaNova's portfolio in the respiratory support market, aligning with its strategy to expand into mechanical circulatory and respiratory assist technologies. ALung collaborates with other companies under LivaNova, fostering innovation in critical care solutions for hospitals and healthcare providers.

• Employees 11
• Founded 1997
• Annual Revenue $7500000
• Total Funding $86062890